Loring Wolcott & Coolidge Fiduciary Advisors LLP Viatris Inc Transaction History
Loring Wolcott & Coolidge Fiduciary Advisors LLP
- $11.1 Billion
- Q3 2024
A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Viatris Inc stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 3,549 shares of VTRS stock, worth $44,575. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,549
Previous 3,640
2.5%
Holding current value
$44,575
Previous $38,000
7.89%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding VTRS
# of Institutions
1,102Shares Held
933MCall Options Held
2.71MPut Options Held
2.4M-
Vanguard Group Inc Valley Forge, PA141MShares$1.77 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.16 Billion0.02% of portfolio
-
State Street Corp Boston, MA63.1MShares$793 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$787 Million4.18% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD48.8MShares$613 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $15.2B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...